Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Inder Verma

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Cell Line

Procedures

Gene Therapy

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Saberi Maziyar; Woods Niels-Bjarne; de Luca Carl; Schenk Simon; Lu Juu Chin; Bandyopadhyay Gautam; Verma Inder M; Olefsky Jerrold M
Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice.
Raya Angel; Rodríguez-Pizà Ignasi; Guenechea Guillermo; Vassena Rita; Navarro Susana; Barrero María José; Consiglio Antonella; Castellà Maria; Río Paula; Sleep Eduard; González Federico; Tiscornia Gustavo; Garreta Elena; Aasen Trond; Veiga Anna; Verma Inder M; Surrallés Jordi; Bueren Juan; Izpisúa Belmonte Juan Carlos
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.
Xia Yifeng; Padre Roanna C; De Mendoza Tatiana Hurtado; Bottero Virginie; Tergaonkar Vinay B; Verma Inder M
Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Inder Verma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Saberi Maziyar; Woods Niels-Bjarne; de Luca Carl; Schenk Simon; Lu Juu Chin; Bandyopadhyay Gautam; Verma Inder M; Olefsky Jerrold M
Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice.
Cell metabolism 2009;10(5):419-29.
2009: Raya Angel; Rodríguez-Pizà Ignasi; Guenechea Guillermo; Vassena Rita; Navarro Susana; Barrero María José; Consiglio Antonella; Castellà Maria; Río Paula; Sleep Eduard; González Federico; Tiscornia Gustavo; Garreta Elena; Aasen Trond; Veiga Anna; Verma Inder M; Surrallés Jordi; Bueren Juan; Izpisúa Belmonte Juan Carlos
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.
Nature 2009;460(7251):53-9.
2009: Xia Yifeng; Padre Roanna C; De Mendoza Tatiana Hurtado; Bottero Virginie; Tergaonkar Vinay B; Verma Inder M
Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(8):2629-34.
2009: Marumoto Tomotoshi; Tashiro Ayumu; Friedmann-Morvinski Dinorah; Scadeng Miriam; Soda Yasushi; Gage Fred H; Verma Inder M
Development of a novel mouse glioma model using lentiviral vectors.
Nature medicine 2009;15(1):110-6.
2009: Smith Jeramiah J; Putta Srikrishna; Zhu Wei; Pao Gerald M; Verma Inder M; Hunter Tony; Bryant Susan V; Gardiner David M; Harkins Timothy T; Voss S Randal
Genic regions of a large salamander genome contain long introns and novel genes.
BMC genomics 2009;10():19.
2009: Monaghan James R; Epp Leonard G; Putta Srikrishna; Page Robert B; Walker John A; Beachy Chris K; Zhu Wei; Pao Gerald M; Verma Inder M; Hunter Tony; Bryant Susan V; Gardiner David M; Harkins Tim T; Voss S Randal
Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration.
BMC biology 2009;7():1.
2008: Singer Oded; Verma Inder M
Applications of lentiviral vectors for shRNA delivery and transgenesis.
Current gene therapy 2008;8(6):483-8.
2008: Suzuki Kotaro; Verma Inder M
Phosphorylation of SNAP-23 by IkappaB kinase 2 regulates mast cell degranulation.
Cell 2008;134(3):485-95.
2008: El-Amouri Salim S; Zhu Hong; Yu Jin; Marr Robert; Verma Inder M; Kindy Mark S
Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.
The American journal of pathology 2008;172(5):1342-54.
2008: Spencer Brian; Marr Robert A; Rockenstein Edward; Crews Leslie; Adame Anthony; Potkar Rewati; Patrick Christina; Gage Fred H; Verma Inder M; Masliah Eliezer
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.
BMC neuroscience 2008;9():109.
2007: McLaughlin Jami; Cheng Donghui; Singer Oded; Lukacs Rita U; Radu Caius G; Verma Inder M; Witte Owen N
Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(51):20501-6.
2007: Pulivarthy Sandhya R; Tanaka Nobushige; Welsh David K; De Haro Luciano; Verma Inder M; Panda Satchidananda
Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(51):20356-61.
2007: Bissig Karl-Dimiter; Le Tam T; Woods Niels-Bjarne; Verma Inder M
Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(51):20507-11.
2007: Irelan Jeffrey T; Murphy Thomas J; DeJesus Paul D; Teo Hsiangling; Xu Dingyue; Gomez-Ferreria Maria A; Zhou Yingyao; Miraglia Loren J; Rines Daniel R; Verma Inder M; Sharp David J; Tergaonkar Vinay; Chanda Sumit K
A role for IkappaB kinase 2 in bipolar spindle assembly.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(43):16940-5.
2007: Liao Wei; Nguyen M T Audrey; Yoshizaki Takeshi; Favelyukis Svetlana; Patsouris David; Imamura Takeshi; Verma Inder M; Olefsky Jerrold M
Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.
American journal of physiology. Endocrinology and metabolism 2007;293(1):E219-27.
2007: Michalkiewicz Mieczyslaw; Michalkiewicz Teresa; Geurts Aron M; Roman Richard J; Slocum Glenn R; Singer Oded; Weihrauch Dorothee; Greene Andrew S; Kaldunski Mary; Verma Inder M; Jacob Howard J; Cowley Allen W
Efficient transgenic rat production by a lentiviral vector.
American journal of physiology. Heart and circulatory physiology 2007;293(1):H881-94.
2007: El-Amouri Salim S; Zhu Hong; Yu Jin; Gage Fred H; Verma Inder M; Kindy Mark S
Neprilysin protects neurons against Abeta peptide toxicity.
Brain research 2007;1152():191-200.
2007: Liu Andrew C; Welsh David K; Ko Caroline H; Tran Hien G; Zhang Eric E; Priest Aaron A; Buhr Ethan D; Singer Oded; Meeker Kirsten; Verma Inder M; Doyle Francis J; Takahashi Joseph S; Kay Steve A
Intercellular coupling confers robustness against mutations in the SCN circadian clock network.
Cell 2007;129(3):605-16.
2007: Spencer Brian J; Verma Inder M
Targeted delivery of proteins across the blood-brain barrier.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(18):7594-9.
2007: Hoffmann Alexander; Xia Yifeng; Verma Inder M
Inflammatory tales of liver cancer.
Cancer cell 2007;11(2):99-101.
2007: Basak Soumen; Kim Hana; Kearns Jeffrey D; Tergaonkar Vinay; O'Dea Ellen; Werner Shannon L; Benedict Chris A; Ware Carl F; Ghosh Gourisankar; Verma Inder M; Hoffmann Alexander
A fourth IkappaB protein within the NF-kappaB signaling module.
Cell 2007;128(2):369-81.
2006: Ghosh Sourav; Tergaonkar Vinay; Rothlin Carla V; Correa Ricardo G; Bottero Virginie; Bist Pradeep; Verma Inder M; Hunter Tony
Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.
Cancer cell 2006;10(3):215-26.
2006: Bottero V; Withoff S; Verma I M
NF-kappaB and the regulation of hematopoiesis.
Cell death and differentiation 2006;13(5):785-97.
2006: Liao Wei; Nguyen M T Audrey; Imamura Takeshi; Singer Oded; Verma Inder M; Olefsky Jerrold M
Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes.
Endocrinology 2006;147(5):2245-52.
2006: Woods Niels-Bjarne; Bottero Virginie; Schmidt Manfred; von Kalle Christof; Verma Inder M
Gene therapy: therapeutic gene causing lymphoma.
Nature 2006;440(7088):1123.
2006: Tanaka Nobushige; Ikawa Masahito; Mata Nathan L; Verma Inder M
Choroidal neovascularization in transgenic mice expressing prokineticin 1: an animal model for age-related macular degeneration.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;13(3):609-16.
2006: Singer Oded; Tiscornia Gustavo; Ikawa Masahito; Verma Inder M
Rapid generation of knockdown transgenic mice by silencing lentiviral vectors.
Nature protocols 2006;1(1):286-92.
2006: Tiscornia Gustavo; Singer Oded; Verma Inder M
Production and purification of lentiviral vectors.
Nature protocols 2006;1(1):241-5.
2006: Tiscornia Gustavo; Singer Oded; Verma Inder M
Design and cloning of lentiviral vectors expressing small interfering RNAs.
Nature protocols 2006;1(1):234-40.
2005: Dhawan Jyotsna; Gokhale Rajesh S; Verma Inder M
Bioscience in India: times are changing.
Cell 2005;123(5):743-5.
2005: Hovatta Iiris; Tennant Richard S; Helton Robert; Marr Robert A; Singer Oded; Redwine Jeffrey M; Ellison Julie A; Schadt Eric E; Verma Inder M; Lockhart David J; Barlow Carrolee
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice.
Nature 2005;438(7068):662-6.
2005: Li Qiutang; Lu Qingxian; Estepa Gabriela; Verma Inder M
Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(44):15977-82.
2005: Verma Inder M
From one experiment to the next.
BioTechniques 2005;39(4):443.
2005: Singer Oded; Marr Robert A; Rockenstein Edward; Crews Leslie; Coufal Nicole G; Gage Fred H; Verma Inder M; Masliah Eliezer
Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.
Nature neuroscience 2005;8(10):1343-9.
2005: Tergaonkar Vinay; Correa Ricardo G; Ikawa Masahito; Verma Inder M
Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.
Nature cell biology 2005;7(9):921-3.
2005: Li Qiutang; Lu Qingxian; Bottero Virginie; Estepa Gabriela; Morrison Lisa; Mercurio Frank; Verma Inder M
Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).
Proceedings of the National Academy of Sciences of the United States of America 2005;102(35):12425-30.
2005: Correa Ricardo G; Matsui Takaaki; Tergaonkar Vinay; Rodriguez-Esteban Concepcion; Izpisua-Belmonte Juan Carlos; Verma Inder M
Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity.
Current biology : CB 2005;15(14):1291-5.
2005: Verma Inder
Then and now.
Nature 2005;436(7050):478-9.
2005: Blesch Armin; Conner James; Pfeifer Alexander; Gasmi Mehdi; Ramirez Anthony; Britton William; Alfa Ron; Verma Inder; Tuszynski Mark H
Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(6):916-25.
2005: Li Qiutang; Withoff Sebo; Verma Inder M
Inflammation-associated cancer: NF-kappaB is the lynchpin.
Trends in immunology 2005;26(6):318-25.
2005: Verma Inder M
Interview with Dr Verma.
Gene therapy 2005;12(12):950-3.
2005: Wang Lili; Calcedo Roberto; Nichols Timothy C; Bellinger Dwight A; Dillow Aaron; Verma Inder M; Wilson James M
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy.
Blood 2005;105(8):3079-86.
2005: Galimi Francesco; Summers Robert G; van Praag Henriette; Verma Inder M; Gage Fred H
A role for bone marrow-derived cells in the vasculature of noninjured CNS.
Blood 2005;105(6):2400-2.
2005: Dodart Jean-Cosme; Marr Robert A; Koistinaho Milla; Gregersen Beth M; Malkani Seema; Verma Inder M; Paul Steven M
Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(4):1211-6.
2005: Galimi Francesco; Saez Enrique; Gall Jason; Hoong Nien; Cho Gerald; Evans Ronald M; Verma Inder M
Development of ecdysone-regulated lentiviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;11(1):142-8.
2005: Verma Inder M; Weitzman Matthew D
Gene therapy: twenty-first century medicine.
Annual review of biochemistry 2005;74():711-38.
2004: Verma I M
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
Annals of the rheumatic diseases 2004;63 Suppl 2():ii57-ii61.
2004: Austin Christopher P; Battey James F; Bradley Allan; Bucan Maja; Capecchi Mario; Collins Francis S; Dove William F; Duyk Geoffrey; Dymecki Susan; Eppig Janan T; Grieder Franziska B; Heintz Nathaniel; Hicks Geoff; Insel Thomas R; Joyner Alexandra; Koller Beverly H; Lloyd K C Kent; Magnuson Terry; Moore Mark W; Nagy Andras; Pollock Jonathan D; Roses Allen D; Sands Arthur T; Seed Brian; Skarnes William C; Snoddy Jay; Soriano Philippe; Stewart David J; Stewart Francis; Stillman Bruce; Varmus Harold; Varticovski Lyuba; Verma Inder M; Vogt Thomas F; von Melchner Harald; Witkowski Jan; Woychik Richard P; Wurst Wolfgang; Yancopoulos George D; Young Stephen G; Zambrowicz Brian
The knockout mouse project.
Nature genetics 2004;36(9):921-4.
2004: Verma Inder M
Doping, gene transfer and sport.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(3):405.
2004: Verma Inder M
Musings for young scientists.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(2):201.
2004: Verma Inder M
Agbiotech: success depends on trust.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(1):1.
2004: Ducut Sigala Jeanette L; Bottero Virginie; Young David B; Shevchenko Andrej; Mercurio Frank; Verma Inder M
Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit.
Science (New York, N.Y.) 2004;304(5679):1963-7.
2004: Verma Inder M
Visa crisis hurts U.S. science.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(6):767.
2004: Correa Ricardo G; Tergaonkar Vinay; Ng Jennifer K; Dubova Ilir; Izpisua-Belmonte Juan Carlos; Verma Inder M
Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development.
Molecular and cellular biology 2004;24(12):5257-68.
2004: Verma Inder M
Stem cell politics get dirty.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(5):633.
2004: Tiscornia Gustavo; Tergaonkar Vinay; Galimi Francesco; Verma Inder M
CRE recombinase-inducible RNA interference mediated by lentiviral vectors.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(19):7347-51.
2004: Kankkonen Hanna M; Vähäkangas Elisa; Marr Robert A; Pakkanen Timo; Laurema Anniina; Leppänen Pia; Jalkanen Johanna; Verma Inder M; Ylä-Herttuala Seppo
Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(4):548-56.
2004: Singer Oded; Yanai Amiel; Verma Inder M
Silence of the genes.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(15):5313-4.
2004: Verma Inder M
AIDS: no end in sight.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(2):141.
2004: Marr Robert A; Guan Hanjun; Rockenstein Edward; Kindy Mark; Gage Fred H; Verma Inder; Masliah Eliezer; Hersh Louis B
Neprilysin regulates amyloid Beta peptide levels.
Journal of molecular neuroscience : MN 2004;22(1-2):5-11.
2003: Tergaonkar Vinay; Bottero Virginie; Ikawa Masahito; Li Qiutang; Verma Inder M
IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
Molecular and cellular biology 2003;23(22):8070-83.
2003: Takabe Kazuaki; Wang Lili; Leal Angela M O; Macconell Leigh A; Wiater Ezra; Tomiya Tomoaki; Ohno Akihiko; Verma Inder M; Vale Wylie
Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats.
Hepatology (Baltimore, Md.) 2003;38(5):1107-15.
2003: Verma Inder M
Fraud and deception in science.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(4):519.
2003: Ikawa Masahito; Tanaka Nobushige; Kao Winston W-Y; Verma Inder M
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(4):666-73.
2003: Kanazawa Yoshiyuki; Verma Inder M
Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver.
Proceedings of the National Academy of Sciences of the United States of America 2003;100 Suppl 1():11850-3.
2003: Gage Fred H; Verma Inder M
Stem cells at the dawn of the 21st century.
Proceedings of the National Academy of Sciences of the United States of America 2003;100 Suppl 1():11817-8.
2003: Verma Inder M
Illiteracy, ignorance, intolerance=terrorism.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(1):1.
2003: Verma Inder M
SARS: fear of global pandemic.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(6):711.
2003: Shin Sook; Verma Inder M
BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(12):7201-6.
2003: Verma Inder M
Good-bye Dolly.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(5 Pt 1):565.
2003: Kootstra Neeltje A; Matsumura Ryusuke; Verma Inder M
Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(5 Pt 1):623-31.
2003: Verma Inder M
The DNA helix at 50.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(4):427.
2003: Marr Robert A; Rockenstein Edward; Mukherjee Atish; Kindy Mark S; Hersh Louis B; Gage Fred H; Verma Inder M; Masliah Eliezer
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(6):1992-6.
2003: Verma Inder M
A voluntary moratorium?
Molecular therapy : the journal of the American Society of Gene Therapy 2003;7(2):141.
2003: Tiscornia Gustavo; Singer Oded; Ikawa Masahito; Verma Inder M
A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(4):1844-8.
2003: Kootstra Neeltje A; Munk Carsten; Tonnu Nina; Landau Nathaniel R; Verma Inder M
Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(3):1298-303.
2003: Xia Yan; Pao Gerald M; Chen Hong-Wu; Verma Inder M; Hunter Tony
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
The Journal of biological chemistry 2003;278(7):5255-63.
2003: Kootstra Neeltje A; Verma Inder M
Gene therapy with viral vectors.
Annual review of pharmacology and toxicology 2003;43():413-39.
2002: Verma Inder
2002 Nobel Prize for physiology and medicine.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(6):698.
2002: Verma Inder M
Making the promise a reality.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(6):695.
2002: Verma Inder M
Success and setback: another adverse event.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(5):565-6.
2002: Verma Inder M
Politics and scientific publishing: noli me tangere.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(4):431.
2002: Li Qiutang; Verma Inder M
NF-kappaB regulation in the immune system.
Nature reviews. Immunology 2002;2(10):725-34.
2002: Galimi Francesco; Noll Meenakshi; Kanazawa Yoshiyuki; Lax Timothy; Chen Cindy; Grompe Markus; Verma Inder M
Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
Blood 2002;100(8):2732-6.
2002: MacKenzie Tippi C; Kobinger Gary P; Kootstra Neeltje A; Radu Antoneta; Sena-Esteves Miguel; Bouchard Sarah; Wilson James M; Verma Inder M; Flake Alan W
Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(3):349-58.
2002: Pan Dao; Gunther Roland; Duan Weiming; Wendell Steve; Kaemmerer William; Kafri Tal; Verma Inder M; Whitley Chester B
Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(1):19-29.
2002: Verma Inder M
Hypothesis-driven science.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;6(1):1.
2002: Tergaonkar Vinay; Pando Matthew; Vafa Omid; Wahl Geoffrey; Verma Inder
p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy.
Cancer cell 2002;1(5):493-503.
2002: Verma Inder M
Do not ban therapeutic cloning.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(6):651.
2002: Ikawa Masahito; Tergaonkar Vinay; Ogura Atsuo; Ogonuki Narumi; Inoue Kimiko; Verma Inder M
Restoration of spermatogenesis by lentiviral gene transfer: offspring from infertile mice.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(11):7524-9.
2002: Verma Inder M
Politics and AIDS: a bad mix.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(5 Pt 1):485.
2002: Verma Inder M
Censorship of scientific publications: a bad idea.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(4):337.
2002: Verma Inder M
A gene therapy institute for NIH?
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(3):213.
2002: Leal Angela M O; Takabe Kazuaki; Wang Lili; Donaldson Cynthia J; MacConell Leigh A; Bilezikjian Louise M; Verma Inder M; Vale Wylie
Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo.
Endocrinology 2002;143(3):964-9.
2002: Pfeifer Alexander; Ikawa Masahito; Dayn Yelena; Verma Inder M
Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(4):2140-5.
2002: Kaspar Brian K; Vissel Bryce; Bengoechea Tasha; Crone Steven; Randolph-Moore Lynne; Muller Rolf; Brandon Eugene P; Schaffer David; Verma Inder M; Lee Kuo-Fen; Heinemann Stephen F; Gage Fred H
Adeno-associated virus effectively mediates conditional gene modification in the brain.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(4):2320-5.
2002: Verma Inder M
Biopiracy: distrust widens the rich-poor divide.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(2):95.
2002: Kessler T A; Pfeifer A; Silletti S; Mesters R M; Berdel W E; Verma I; Cheresh D
Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.
Annals of hematology 2002;81 Suppl 2():S69-70.
2002: Galimi F; Verma I M
Opportunities for the use of lentiviral vectors in human gene therapy.
Current topics in microbiology and immunology 2002;261():245-54.
2001: Verma I M
Gene therapy and jurisprudence.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(5):393.
2001: Lamberti C; Lin K M; Yamamoto Y; Verma U; Verma I M; Byers S; Gaynor R B
Regulation of beta-catenin function by the IkappaB kinases.
The Journal of biological chemistry 2001;276(45):42276-86.
2001: Pfeifer A; Brandon E P; Kootstra N; Gage F H; Verma I M
Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(20):11450-5.
2001: Verma I M
Are the benefits of stem cells being oversold?
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(3):161.
2001: Verma I M
Adverse event reporting: essential for science and public trust.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(2):83.
2001: McAllister-Lucas L M; Inohara N; Lucas P C; Ruland J; Benito A; Li Q; Chen S; Chen F F; Yamaoka S; Verma I M; Mak T W; Núñez G
Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction.
The Journal of biological chemistry 2001;276(33):30589-97.
2001: Verma I M
Germline gene therapy: yes or no?
Molecular therapy : the journal of the American Society of Gene Therapy 2001;4(1):1.
2001: Verma I M
Ombudsman or hotline for Gene therapy clinical trials?
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(6):817-8.
2001: Verma I M
Stem cell research: win, win, win by keeping politics out.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(5 Pt 1):641.
2001: Ruffner H; Joazeiro C A; Hemmati D; Hunter T; Verma I M
Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(9):5134-9.
2001: Verma I M
Pharma + profits = continued aids epidemic.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(4):419.
2001: Pfeifer A; Kessler T; Yang M; Baranov E; Kootstra N; Cheresh D A; Hoffman R M; Verma I M
Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(3):319-22.
2001: Xu K; Ma H; McCown T J; Verma I M; Kafri T
Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.
Molecular therapy : the journal of the American Society of Gene Therapy 2001;3(1):97-104.
2001: Pfeifer A; Verma I M
Gene therapy: promises and problems.
Annual review of genomics and human genetics 2001;2():177-211.
2000: Verma I M
Gene therapy: the need for basic science.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(6):531.
2000: Somia N; Verma I M
Gene therapy: trials and tribulations.
Nature reviews. Genetics 2000;1(2):91-9.
2000: Verma I M
A tumultuous year for gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(5):415-6.
2000: Pfeifer A; Kessler T; Silletti S; Cheresh D A; Verma I M
Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12227-32.
2000: Verma I M
AIDS: are we doing enough?
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(4):299.
2000: Verma I M
Gene therapy: public education.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(3):177.
2000: Verma I M; Gage F H
Genome and gene therapy.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(2):95.
2000: Li Q; Estepa G; Memet S; Israel A; Verma I M
Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.
Genes & development 2000;14(14):1729-33.
2000: Pando M P; Verma I M
Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha.
The Journal of biological chemistry 2000;275(28):21278-86.
2000: Kafri T; van Praag H; Gage F H; Verma I M
Lentiviral vectors: regulated gene expression.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(6):516-21.
2000: Verma I M
Gene therapy: beyond 2000.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(6):493.
2000: Somia N V; Miyoshi H; Schmitt M J; Verma I M
Retroviral vector targeting to human immunodeficiency virus type 1-infected cells by receptor pseudotyping.
Journal of virology 2000;74(9):4420-4.
2000: Wang L; Nichols T C; Read M S; Bellinger D A; Verma I M
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(2):154-8.
2000: Pao G M; Janknecht R; Ruffner H; Hunter T; Verma I M
CBP/p300 interact with and function as transcriptional coactivators of BRCA1.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(3):1020-5.
2000: Miyazaki T; Katagiri H; Kanegae Y; Takayanagi H; Sawada Y; Yamamoto A; Pando M P; Asano T; Verma I M; Oda H; Nakamura K; Tanaka S
Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts.
The Journal of cell biology 2000;148(2):333-42.
2000: Naldini L; Verma I M
Lentiviral vectors.
Advances in virus research 2000;55():599-609.
1999: Spain B H; Larson C J; Shihabuddin L S; Gage F H; Verma I M
Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(24):13920-5.
1999: Somia N V; Schmitt M J; Vetter D E; Van Antwerp D; Heinemann S F; Verma I M
LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(22):12667-72.
1999: Takahashi M; Miyoshi H; Verma I M; Gage F H
Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer.
Journal of virology 1999;73(9):7812-6.
1999: Ruffner H; Jiang W; Craig A G; Hunter T; Verma I M
BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site.
Molecular and cellular biology 1999;19(7):4843-54.
1999: Li Q; Lu Q; Hwang J Y; Büscher D; Lee K F; Izpisua-Belmonte J C; Verma I M
IKK1-deficient mice exhibit abnormal development of skin and skeleton.
Genes & development 1999;13(10):1322-8.
1999: Li Q; Van Antwerp D; Mercurio F; Lee K F; Verma I M
Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.
Science (New York, N.Y.) 1999;284(5412):321-5.
1999: Wang L; Takabe K; Bidlingmaier S M; Ill C R; Verma I M
Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):3906-10.
1999: Somia N V; Kafri T; Verma I M
Piecing together more efficient gene expression.
Nature biotechnology 1999;17(3):224-5.
1999: Miyoshi H; Smith K A; Mosier D E; Verma I M; Torbett B E
Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.
Science (New York, N.Y.) 1999;283(5402):682-6.
1999: Kafri T; van Praag H; Ouyang L; Gage F H; Verma I M
A packaging cell line for lentivirus vectors.
Journal of virology 1999;73(1):576-84.
1999: Verma I M
From reverse transcriptase to gene therapy: a marvelous journey.
Harvey lectures 1999;95():43-66.
1998: Gallichan W S; Kafri T; Krahl T; Verma I M; Sarvetnick N
Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis.
Human gene therapy 1998;9(18):2717-26.
1998: Miyoshi H; Blömer U; Takahashi M; Gage F H; Verma I M
Development of a self-inactivating lentivirus vector.
Journal of virology 1998;72(10):8150-7.
1998: Kafri T; Morgan D; Krahl T; Sarvetnick N; Sherman L; Verma I
Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(19):11377-82.
1998: Schwarz E M; Badorff C; Hiura T S; Wessely R; Badorff A; Verma I M; Knowlton K U
NF-kappaB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: a mechanism of resistance in p50 knockout mice.
Journal of virology 1998;72(7):5654-60.
1998: Kanegae Y; Tavares A T; Izpisúa Belmonte J C; Verma I M
Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb.
Nature 1998;392(6676):611-4.
1998: Van Antwerp D J; Martin S J; Verma I M; Green D R
Inhibition of TNF-induced apoptosis by NF-kappa B.
Trends in cell biology 1998;8(3):107-11.
1998: Blömer U; Kafri T; Randolph-Moore L; Verma I M; Gage F H
Bcl-xL protects adult septal cholinergic neurons from axotomized cell death.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(5):2603-8.
1997: Kafri T; Blömer U; Peterson D A; Gage F H; Verma I M
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Nature genetics 1997;17(3):314-7.
1997: Verma I M; Stevenson J
IkappaB kinase: beginning, not the end.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(22):11758-60.
1997: Wang L; Zoppè M; Hackeng T M; Griffin J H; Lee K F; Verma I M
A factor IX-deficient mouse model for hemophilia B gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11563-6.
1997: Verma I M; Somia N
Gene therapy -- promises, problems and prospects.
Nature 1997;389(6648):239-42.
1997: Miyoshi H; Takahashi M; Gage F H; Verma I M
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(19):10319-23.
1997: Blömer U; Naldini L; Kafri T; Trono D; Verma I M; Gage F H
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector.
Journal of virology 1997;71(9):6641-9.
1997: Tashiro K; Pando M P; Kanegae Y; Wamsley P M; Inoue S; Verma I M
Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalpha.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(15):7862-7.
1997: Ruffner H; Verma I M
BRCA1 is a cell cycle-regulated nuclear phosphoprotein.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(14):7138-43.
1997: Carrozza M L; Jacobs H; Acton D; Verma I; Berns A
Overexpression of the FosB2 gene in thymocytes causes aberrant development of T cells and thymic epithelial cells.
Oncogene 1997;14(9):1083-91.
1997: Schwarz E M; Krimpenfort P; Berns A; Verma I M
Immunological defects in mice with a targeted disruption in Bcl-3.
Genes & development 1997;11(2):187-97.
1996: Van Antwerp D J; Verma I M
Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
Molecular and cellular biology 1996;16(11):6037-45.
1996: Van Antwerp D J; Martin S J; Kafri T; Green D R; Verma I M
Suppression of TNF-alpha-induced apoptosis by NF-kappaB.
Science (New York, N.Y.) 1996;274(5288):787-9.
1996: Naldini L; Blömer U; Gage F H; Trono D; Verma I M
Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11382-8.
1996: Naviaux R K; Costanzi E; Haas M; Verma I M
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses.
Journal of virology 1996;70(8):5701-5.
1996: Chapman M S; Verma I M
Transcriptional activation by BRCA1.
Nature 1996;382(6593):678-9.
1996: Schwarz E M; Van Antwerp D; Verma I M
Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha.
Molecular and cellular biology 1996;16(7):3554-9.
1996: Verma I M
"Green light" for gene transfer.
Nature biotechnology 1996;14(5):576.
1996: Naldini L; Blömer U; Gallay P; Ory D; Mulligan R; Gage F H; Verma I M; Trono D
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
Science (New York, N.Y.) 1996;272(5259):263-7.
1996: Blömer U; Naldini L; Verma I M; Trono D; Gage F H
Applications of gene therapy to the CNS.
Human molecular genetics 1996;5 Spec No():1397-404.
1995: Verma I M; Stevenson J K; Schwarz E M; Van Antwerp D; Miyamoto S
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Genes & development 1995;9(22):2723-35.
1995: Barroga C F; Stevenson J K; Schwarz E M; Verma I M
Constitutive phosphorylation of I kappa B alpha by casein kinase II.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(17):7637-41.
1995: Somia N V; Zoppé M; Verma I M
Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(16):7570-4.
1995: Dai Y; Schwarz E M; Gu D; Zhang W W; Sarvetnick N; Verma I M
Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(5):1401-5.
1995: Miyamoto S; Cauley K; Verma I M
Ultraviolet cross-linking of DNA binding proteins.
Methods in enzymology 1995;254():632-41.
1995: Miyamoto S; Verma I M
Rel/NF-kappa B/I kappa B story.
Advances in cancer research 1995;66():255-92.
1994: Miyamoto S; Maki M; Schmitt M J; Hatanaka M; Verma I M
Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(26):12740-4.
1994: Verma I M
Gene therapy: hopes, hypes, and hurdles.
Molecular medicine (Cambridge, Mass.) 1994;1(1):2-3.
1994: Stevens C F; Verma I
Memory. A model with good CREdentials.
Current biology : CB 1994;4(8):736-8.
1994: Bengal E; Flores O; Rangarajan P N; Chen A; Weintraub H; Verma I M
Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(13):6221-5.
1994: Miyamoto S; Schmitt M J; Verma I M
Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(11):5056-60.
1994: Miyamoto S; Chiao P J; Verma I M
Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.
Molecular and cellular biology 1994;14(5):3276-82.
1994: Cauley K; Verma I M
Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(1):390-4.
1994: Chiao P J; Miyamoto S; Verma I M
Autoregulation of I kappa B alpha activity.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(1):28-32.
1993: Wisdon R; Verma I M
Transformation by Fos proteins requires a C-terminal transactivation domain.
Molecular and cellular biology 1993;13(12):7429-38.
1993: Nabel G J; Verma I M
Proposed NF-kappa B/I kappa B family nomenclature.
Genes & development 1993;7(11):2063.
1993: Kerr L D; Ransone L J; Wamsley P; Schmitt M J; Boyer T G; Zhou Q; Berk A J; Verma I M
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B.
Nature 1993;365(6445):412-9.
1993: Polak M; Scharfmann R; Seilheimer B; Eisenbarth G; Dressler D; Verma I M; Potter H
Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(12):5781-5.
1993: Wisdom R; Verma I M
Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation.
Molecular and cellular biology 1993;13(5):2635-43.
1993: Léveillard T; Verma I M
Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins.
Gene expression 1993;3(2):135-50.
1993: Ransone L J; Kerr L D; Schmitt M J; Wamsley P; Verma I M
The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.
Gene expression 1993;3(1):37-48.
1993: Dwarki V J; Malone R W; Verma I M
Cationic liposome-mediated RNA transfection.
Methods in enzymology 1993;217():644-54.
1992: Kerr L D; Duckett C S; Wamsley P; Zhang Q; Chiao P; Nabel G; McKeithan T W; Baeuerle P A; Verma I M
The proto-oncogene bcl-3 encodes an I kappa B protein.
Genes & development 1992;6(12A):2352-63.
1992: Dai Y; Roman M; Naviaux R K; Verma I M
Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(22):10892-5.
1992: Naviaux R K; Verma I M
Retroviral vectors for persistent expression in vivo.
Current opinion in biotechnology 1992;3(5):540-7.
1992: Naughton B A; Dai Y; Sibanda B; Scharfmann R; San Roman J; Zeigler F; Verma I M
Long-term expression of a retrovirally introduced beta-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes.
Somatic cell and molecular genetics 1992;18(5):451-62.
1992: Morgan I M; Ransone L J; Bos T J; Verma I M; Vogt P K
Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Oncogene 1992;7(6):1119-25.
1992: Kerr L D; Inoue J; Verma I M
Signal transduction: the nuclear target.
Current opinion in cell biology 1992;4(3):496-501.
1992: Inoue J; Kerr L D; Rashid D; Davis N; Bose H R; Verma I M
Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(10):4333-7.
1992: Roman M; Axelrod J H; Dai Y; Naviaux R K; Friedmann T; Verma I M
Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle.
Somatic cell and molecular genetics 1992;18(3):247-58.
1992: Wisdom R; Yen J; Rashid D; Verma I M
Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains.
Genes & development 1992;6(4):667-75.
1992: Tratner I; Ofir R; Verma I M
Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential.
Molecular and cellular biology 1992;12(3):998-1006.
1992: Inoue J; Kerr L D; Kakizuka A; Verma I M
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family.
Cell 1992;68(6):1109-20.
1992: Miyanohara A; Johnson P A; Elam R L; Dai Y; Witztum J L; Verma I M; Friedmann T
Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX.
The New biologist 1992;4(3):238-46.
1992: Bengal E; Ransone L; Scharfmann R; Dwarki V J; Tapscott S J; Weintraub H; Verma I M
Functional antagonism between c-Jun and MyoD proteins: a direct physical association.
Cell 1992;68(3):507-19.
1992: Verma I M; Inoue J; Kerr L D; Ofir R; Ransone L J
Oncogenes as transcription factors:implications for signal transduction.
Progress in clinical and biological research 1992;376():41-59.
1991: Tratner I; Verma I M
Identification of a nuclear targeting sequence in the Fos protein.
Oncogene 1991;6(11):2049-53.
1991: Kerr L D; Inoue J; Davis N; Link E; Baeuerle P A; Bose H R; Verma I M
The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.
Genes & development 1991;5(8):1464-76.
1991: Schüle R; Rangarajan P; Yang N; Kliewer S; Ransone L J; Bolado J; Verma I M; Evans R M
Retinoic acid is a negative regulator of AP-1-responsive genes.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(14):6092-6.
1991: Yen J; Wisdom R M; Tratner I; Verma I M
An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(12):5077-81.
1991: Scharfmann R; Axelrod J H; Verma I M
Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(11):4626-30.
1991: Verma I M; Naviaux R K
Human gene therapy.
Current opinion in genetics & development 1991;1(1):54-9.
1991: Inoue J; Kerr L D; Ransone L J; Bengal E; Hunter T; Verma I M
c-rel activates but v-rel suppresses transcription from kappa B sites.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(9):3715-9.
1991: Ofir R; Dwarki V J; Rashid D; Verma I M
CREB represses transcription of fos promoter: role of phosphorylation.
Gene expression 1991;1(1):55-60.
1990: Verma I M
Gene therapy.
Scientific American 1990;263(5):68-72, 81-4.
1990: Wisdom R; Verma I M
Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant.
Molecular and cellular biology 1990;10(11):5626-33.
1990: Ofir R; Dwarki V J; Rashid D; Verma I M
Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter.
Nature 1990;348(6296):80-2.
1990: Bull P; Morley K L; Hoekstra M F; Hunter T; Verma I M
The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain.
Molecular and cellular biology 1990;10(10):5473-85.
1990: Schüle R; Rangarajan P; Kliewer S; Ransone L J; Bolado J; Yang N; Verma I M; Evans R M
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.
Cell 1990;62(6):1217-26.
1990: Ransone L J; Wamsley P; Morley K L; Verma I M
Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins.
Molecular and cellular biology 1990;10(9):4565-73.
1990: Axelrod J H; Read M S; Brinkhous K M; Verma I M
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(13):5173-7.
1990: Li C L; Dwarki V J; Verma I M
Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4349-53.
1990: Lamph W W; Dwarki V J; Ofir R; Montminy M; Verma I M
Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4320-4.
1990: Ransone L J; Visvader J; Wamsley P; Verma I M
Trans-dominant negative mutants of Fos and Jun.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3806-10.
1990: Ivashkiv L B; Liou H C; Kara C J; Lamph W W; Verma I M; Glimcher L H
mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element.
Molecular and cellular biology 1990;10(4):1609-21.
1990: Sassone-Corsi P; Ransone L J; Verma I M
Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements.
Oncogene 1990;5(3):427-31.
1990: Tratner I; De Togni P; Sassone-Corsi P; Verma I M
Characterization and purification of human fos protein generated in insect cells with a baculoviral expression vector.
Journal of virology 1990;64(2):499-508.
1990: Dwarki V J; Montminy M; Verma I M
Both the basic region and the 'leucine zipper' domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation.
The EMBO journal 1990;9(1):225-32.
1990: Kindy M S; Verma I M
Developmental expression of the Xenopus laevis fos protooncogene.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(1):27-37.
1990: Ransone L J; Verma I M
Nuclear proto-oncogenes fos and jun.
Annual review of cell biology 1990;6():539-57.
1990: Verma I M; Ransone L J; Visvader J; Sassone-Corsi P; Lamph W W
fos-jun conspiracy: implications for the cell.
Ciba Foundation symposium 1990;150():128-37; discussion 137-46.
1990: Atwater J A; Wisdom R; Verma I M
Regulated mRNA stability.
Annual review of genetics 1990;24():519-41.
1989: Valerio D; Einerhand M P; Wamsley P M; Bakx T A; Li C L; Verma I M
Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeat.
Gene 1989;84(2):419-27.
1989: Bull P; Hunter T; Verma I M
Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts.
Molecular and cellular biology 1989;9(11):5239-43.
1989: Malone R W; Felgner P L; Verma I M
Cationic liposome-mediated RNA transfection.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(16):6077-81.
1989: Sassone-Corsi P; Der C J; Verma I M
ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun.
Molecular and cellular biology 1989;9(8):3174-83.
1989: Ransone L J; Verma I M
Association of nuclear oncoproteins fos and jun.
Current opinion in cell biology 1989;1(3):536-40.
1989: Ransone L J; Visvader J; Sassone-Corsi P; Verma I M
Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins.
Genes & development 1989;3(6):770-81.
1989: Fujii M; Shalloway D; Verma I M
Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos.
Molecular and cellular biology 1989;9(6):2493-9.
1989: Visvader J; Verma I M
Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes.
Molecular and cellular biology 1989;9(3):1336-41.
1989: Verma I M; Ransone L J; Visvader J; Sassone-Corsi P; Lamph W W
fos-jun Conspiracy: implications for the cell.
Princess Takamatsu symposia 1989;20():119-26.
1989: Ransone L J; Visvader J; Lamph W W; Sassone-Corsi P; Verma I M
fos and jun interaction: the role of the leucine zipper.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1989;4():10-21.
1989: Raymond V; Atwater J A; Verma I M
Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos.
Oncogene research 1989;5(1):1-12.
1988: Sassone-Corsi P; Ransone L J; Lamph W W; Verma I M
Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.
Nature 1988;336(6200):692-5.
1988: Sassone-Corsi P; Visvader J; Ferland L; Mellon P L; Verma I M
Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element.
Genes & development 1988;2(12A):1529-38.
1988: Visvader J; Sassone-Corsi P; Verma I M
Two adjacent promoter elements mediate nerve growth factor activation of the c-fos gene and bind distinct nuclear complexes.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9474-8.
1988: Fujii M; Sassone-Corsi P; Verma I M
c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(22):8526-30.
1988: Sassone-Corsi P; Lamph W W; Kamps M; Verma I M
fos-associated cellular p39 is related to nuclear transcription factor AP-1.
Cell 1988;54(4):553-60.
1988: Lamph W W; Wamsley P; Sassone-Corsi P; Verma I M
Induction of proto-oncogene JUN/AP-1 by serum and TPA.
Nature 1988;334(6183):629-31.
1988: Sassone-Corsi P; Sisson J C; Verma I M
Transcriptional autoregulation of the proto-oncogene fos.
Nature 1988;334(6180):314-9.
1988: St Louis D; Verma I M
An alternative approach to somatic cell gene therapy.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(9):3150-4.
1988: De Togni P; Niman H; Raymond V; Sawchenko P; Verma I M
Detection of fos protein during osteogenesis by monoclonal antibodies.
Molecular and cellular biology 1988;8(5):2251-6.
1988: Sassone-Corsi P; Lamph W W; Verma I M
Regulation of proto-oncogene fos: a paradigm for early response genes.
Cold Spring Harbor symposia on quantitative biology 1988;53 Pt 2():749-60.
1988: Barber J R; Sassone-Corsi P; Verma I M
Proto-oncogene fos expression and post-translational modification.
Progress in clinical and biological research 1988;266():23-37.
1987: Verma I M; Sassone-Corsi P
Proto-oncogene fos: complex but versatile regulation.
Cell 1987;51(4):513-4.
1987: Barber J R; Verma I M
Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
Molecular and cellular biology 1987;7(6):2201-11.
1987: Sassone-Corsi P; Verma I M
Modulation of c-fos gene transcription by negative and positive cellular factors.
Nature 1987;326(6112):507-10.
1987: Billestrup N; Mitchell R L; Vale W; Verma I M
Growth hormone-releasing factor induces c-fos expression in cultured primary pituitary cells.
Molecular endocrinology (Baltimore, Md.) 1987;1(4):300-5.
1987: Anson D S; Hock R A; Austen D; Smith K J; Brownlee G G; Verma I M; Miller A D
Towards gene therapy for hemophilia B.
Molecular biology & medicine 1987;4(1):11-20.
1987: McIvor R S; Johnson M J; Miller A D; Pitts S; Williams S R; Valerio D; Martin D W; Verma I M
Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses.
Molecular and cellular biology 1987;7(2):838-46.
1987: Van Beveren C; Mitchell R L; Henning-Chubb C; Huberman E; Verma I M
Expression of the c-fos gene during differentiation.
Advances in experimental medicine and biology 1987;213():263-74.
1987: Barber J R; Sassone-Corsi P; Verma I M
Proto-oncogene fos: factors affecting expression and covalent modification of the gene product.
Annals of the New York Academy of Sciences 1987;511():117-30.
1987: Verma I M; Graham W R
The fos oncogene.
Advances in cancer research 1987;49():29-52.
1986: Kruijer W; Skelly H; Botteri F; van der Putten H; Barber J R; Verma I M; Leffert H L
Proto-oncogene expression in regenerating liver is simulated in cultures of primary adult rat hepatocytes.
The Journal of biological chemistry 1986;261(17):7929-33.
1986: Mitchell R L; Henning-Chubb C; Huberman E; Verma I M
c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages.
Cell 1986;45(4):497-504.
1986: Coussens L; Van Beveren C; Smith D; Chen E; Mitchell R L; Isacke C M; Verma I M; Ullrich A
Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
Nature 1986;320(6059):277-80.
1986: Chen E; Coussens L; Liao Y C; Smith D; Yang-Feng T L; McGrath J; Van Beveren C; Verma I M; Libermann T A; Schlessinger J
Structural features of growth factor receptors with oncogenic potential.
Biochemical Society symposium 1986;52():65-82.
1986: Verma I M; Deschamps J; Van Beveren C; Sassone-Corsi P
Human fos gene.
Cold Spring Harbor symposia on quantitative biology 1986;51 Pt 2():949-58.
1986: Botteri F M; van der Putten H; Miller A D; Fan H; Verma I M
Recombinant retroviruses in transgenic mice.
Annals of the New York Academy of Sciences 1986;478():255-68.
1986: Verma I M; Mitchell R L; Sassone-Corsi P
Proto-oncogene fos: an inducible gene.
Princess Takamatsu symposia 1986;17():279-90.
1986: Van Beveren C; Verma I M
Homology among oncogenes.
Current topics in microbiology and immunology 1986;123():73-98.
1986: Mitchell R L; Hanks S K; Verma I M
Proto-oncogene fos: an inducible multifaceted gene.
Symposium on Fundamental Cancer Research 1986;39():99-113.
1985: Deschamps J; Meijlink F; Verma I M
Identification of a transcriptional enhancer element upstream from the proto-oncogene fos.
Science (New York, N.Y.) 1985;230(4730):1174-7.
1985: Kruijer W; Schubert D; Verma I M
Induction of the proto-oncogene fos by nerve growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(21):7330-4.
1985: van der Putten H; Botteri F M; Miller A D; Rosenfeld M G; Fan H; Evans R M; Verma I M
Efficient insertion of genes into the mouse germ line via retroviral vectors.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(18):6148-52.
1985: Miller A D; Verma I M; Curran T
Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity.
Journal of virology 1985;55(3):521-6.
1985: Meijlink F; Curran T; Miller A D; Verma I M
Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(15):4987-91.
1985: Miller A D; Law M F; Verma I M
Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene.
Molecular and cellular biology 1985;5(3):431-7.
1985: Curran T; Van Beveren C; Verma I M
Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein.
Molecular and cellular biology 1985;5(1):167-72.
1985: Mitchell R L; Zokas L; Schreiber R D; Verma I M
Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation.
Cell 1985;40(1):209-17.
1985: Deschamps J; Mitchell R L; Meijlink F; Kruijer W; Schubert D; Verma I M
Proto-oncogene fos is expressed during development, differentiation, and growth.
Cold Spring Harbor symposia on quantitative biology 1985;50():733-45.
1984: Kruijer W; Cooper J A; Hunter T; Verma I M
Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein.
Nature 1984;312(5996):711-6.
1984: Cochran B H; Zullo J; Verma I M; Stiles C D
Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor.
Science (New York, N.Y.) 1984;226(4678):1080-2.
1984: Barker P E; Rabin M; Watson M; Breg W R; Ruddle F H; Verma I M
Human c-fos oncogene mapped within chromosomal region 14q21----q31.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(18):5826-30.
1984: Miller A D; Ong E S; Rosenfeld M G; Verma I M; Evans R M
Infectious and selectable retrovirus containing an inducible rat growth hormone minigene.
Science (New York, N.Y.) 1984;225(4666):993-8.
1984: Miller A D; Eckner R J; Jolly D J; Friedmann T; Verma I M
Expression of a retrovirus encoding human HPRT in mice.
Science (New York, N.Y.) 1984;225(4662):630-2.
1984: Lin C R; Chen W S; Kruiger W; Stolarsky L S; Weber W; Evans R M; Verma I M; Gill G N; Rosenfeld M G
Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells.
Science (New York, N.Y.) 1984;224(4651):843-8.
1984: Van Beveren C; Enami S; Curran T; Verma I M
FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes.
Virology 1984;135(1):229-43.
1984: Curran T; Verma I M
FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product.
Virology 1984;135(1):218-28.
1984: Slamon D J; deKernion J B; Verma I M; Cline M J
Expression of cellular oncogenes in human malignancies.
Science (New York, N.Y.) 1984;224(4646):256-62.
1984: Verma I M
From c-fos to v-fos.
Nature 1984;308(5957):317.
1984: Curran T; Miller A D; Zokas L; Verma I M
Viral and cellular fos proteins: a comparative analysis.
Cell 1984;36(2):259-68.
1984: Miller A D; Curran T; Verma I M
c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene.
Cell 1984;36(1):51-60.
1984: Miller A D; Verma I M
Two base changes restore infectivity to a noninfectious molecular clone of Moloney murine leukemia virus (pMLV-1).
Journal of virology 1984;49(1):214-22.
1984: Müller R; Verma I M
Expression of cellular oncogenes.
Current topics in microbiology and immunology 1984;112():73-115.
1983: MacConnell W P; Verma I M
Expression of FBJ-MSV oncogene (fos) product in bacteria.
Virology 1983;131(2):367-74.
1983: Müller R; Tremblay J M; Adamson E D; Verma I M
Tissue and cell type-specific expression of two human c-onc genes.
Nature 1983;304(5925):454-6.
1983: Miller A D; Jolly D J; Friedmann T; Verma I M
A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(15):4709-13.
1983: van Straaten F; Müller R; Curran T; Van Beveren C; Verma I M
Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(11):3183-7.
1983: Müller R; Slamon D J; Adamson E D; Tremblay J M; Müller D; Cline M J; Verma I M
Transcription of c-onc genes c-rasKi and c-fms during mouse development.
Molecular and cellular biology 1983;3(6):1062-9.
1983: Curran T; MacConnell W P; van Straaten F; Verma I M
Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells.
Molecular and cellular biology 1983;3(5):914-21.
1983: Van Beveren C; van Straaten F; Curran T; Müller R; Verma I M
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini.
Cell 1983;32(4):1241-55.
1983: Jolly D J; Esty A C; Subramani S; Friedmann T; Verma I M
Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene.
Nucleic acids research 1983;11(6):1855-72.
1983: Müller R; Verma I M; Adamson E D
Expression of c-onc genes: c-fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion.
The EMBO journal 1983;2(5):679-84.
1982: Curran T; Peters G; Van Beveren C; Teich N M; Verma I M
FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.
Journal of virology 1982;44(2):674-82.
1982: Bosselman R A; van Straaten F; Van Beveren C; Verma I M; Vogt M
Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA.
Journal of virology 1982;44(1):19-31.
1982: Müller R; Slamon D J; Tremblay J M; Cline M J; Verma I M
Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.
Nature 1982;299(5884):640-4.
1982: Papkoff J; Verma I M; Hunter T
Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus.
Cell 1982;29(2):417-26.
1982: Doehmer J; Barinaga M; Vale W; Rosenfeld M G; Verma I M; Evans R M
Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(7):2268-72.
1982: Van Beveren C; Rands E; Chattopadhyay S K; Lowy D R; Verma I M
Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.
Journal of virology 1982;41(2):542-56.
1982: van der Putten H; Quint W; Verma I M; Berns A
Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.
Nucleic acids research 1982;10(2):577-92.
1981: Papkoff J; Lai M H; Hunter T; Verma I M
Analysis of transforming gene products from Moloney murine sarcoma virus.
Cell 1981;27(1 Pt 2):109-19.
1981: Van Beveren C; van Straaten F; Galleshaw J A; Verma I M
Nucleotide sequence of the genome of a murine sarcoma virus.
Cell 1981;27(1 Pt 2):97-108.
1981: Fuhrman S A; Van Beveren C; Verma I M
Identification of a RNA polymerase II initiation site in the long terminal repeat of Moloney murine leukemia viral DNA.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(9):5411-5.
1981: van der Putten H; Quint W; van Raaij J; Maandag E R; Verma I M; Berns A
M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors.
Cell 1981;24(3):729-39.
1981: Van Beveren C; Goddard J G; Berns A J; Verma I M
Biogenesis of a transforming gene.
Molecular biology reports 1981;7(1-3):163-5.
1981: Van Beveren C; Galleshaw J A; Jonas V; Berns A J; Doolittle R F; Donoghue D J; Verma I M
Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus.
Nature 1981;289(5795):258-62.
1980: Berns A J; Lai M H; Bosselman R A; McKennett M A; Bacheler L T; Fan H; Maandag E C; van der Putten H V; Verma I M
Molecular cloning of unintegrated and a portion of integrated moloney murine leukemia viral DNA in bacteriophage lambda.
Journal of virology 1980;36(1):254-63.
1980: Lai M H; Verma I M
Genome organization of retroviruses. VIII. Nonproducer cell lines of mouse fibroblasts transformed by Moloney murine sarcoma virus DNA synthesized in vitro.
Virology 1980;104(2):407-17.
1980: Van Beveren C; Goddard J G; Berns A; Verma I M
Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3307-11.
1980: Sutcliffe J G; Shinnick T M; Verma I M; Lerner R A
Nucleotide sequence of Moloney leukemia virus: 3' end reveals details of replications, analogy to bacterial transposons, and an unexpected gene.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3302-6.
1980: Jones M; Bosselman R A; van der Hoorn F A; Berns A; Fan H; Verma I M
Identification and molecular cloning of Moloney mouse sarcoma virus-specific sequences from uninfected mouse cells.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(5):2651-5.
1980: Verma I M; Lai M H; Bosselman R A; McKennett M A; Fan H; Berns A
Molecular cloning of unintegrated Moloney mouse sarcoma virus DNA in bacteriophage lambda.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(4):1773-7.
1980: Bosselman R A; Van Griensven L J; Vogt M; Verma I M
Genome organization of retroviruses IX. Analysis of the genomes of Friend spleen focus-forming (F-SFFV) and helper murine leukemia viruses by heteroduplex-formation.
Virology 1980;102(1):234-9.
1980: Bosselman R A; Verma I M
Genome organization of retroviruses. V. In vitro-synthesized Moloney murine leukemia viral DNA has long terminal redundancy.
Journal of virology 1980;33(1):487-93.
1980: Lai M H; Verma I M
Genome organization of retroviruses. VII. Infection by double-stranded DNA synthesized in vitro from Moloney murine leukemia virus generates a virus indistinguishable from the original virus used in reverse transcription.
Virology 1980;100(1):194-8.
1980: Sutcliffe J G; Shinnick T M; Lerner R A; Johnson P; Verma I M
Nucleotide sequence of a cloned murine leukemia virus DNA fragment.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 2,():1275-9.
1979: Bosselman R A; Van Griensven L J; Vogt M; Verma I M
Genome organization of retroviruses. VI. Heteroduplex analysis of ecotropic and xenotropic sequences of moloney mink cell focus-inducing viral RNA obtained from either a cloned isolate or a thymoma cell line.
Journal of virology 1979;32(3):968-78.
1979: Chien Y H; Verma I M; Duesberg P H; Davidson N
Heteroduplex analysis of the RNA of clone 3 Moloney murine sarcoma virus.
Journal of virology 1979;32(3):1028-32.
1979: Chien U H; Lai M; Shih T Y; Verma I M; Scolnick E M; Roy-Burman P; Davidson N
Heteroduplex analysis of the sequence relationships between the genomes of Kirsten and Harvey sarcoma viruses, their respective parental murine leukemia viruses, and the rat endogenous 30S RNA.
Journal of virology 1979;31(3):752-60.
1979: Verma I M
Genome organization of retroviruses. III. Restriction endonuclease cleavage maps of mouse sarcoma virus double-stranded DNA synthesized in vitro.
Nucleic acids research 1979;6(5):1863-7.
1978: Chien Y H; Verma I M; Shih T Y; Scolnick E M; Davidson N
Heteroduplex analysis of the sequence relations between the RNAs of mink cell focus-inducing and murine leukemia viruses.
Journal of virology 1978;28(1):352-60.
1978: Lai M H; Verma I M; Tronick S R; Aaronson S A
Mammalian retrovirus-associated RNase H is virus coded.
Journal of virology 1978;27(3):823-5.
1978: Verma I M; McKennett M A
Genome organization of RNA tumor viruses II. Physical maps of in vitro-synthesized Moloney murine leukemia virus double-stranded DNA by restriction endonucleases.
Journal of virology 1978;26(3):630-45.
1978: Verma I M
Genome organization of RNA tumor viruses. I. In vitro synthesis of full-genome-length single-stranded and double-stranded viral DNA transcripts.
Journal of virology 1978;26(3):615-29.
1978: Fan H; Verma I M
Size analysis and relationship of murine leukemia virus-specific mRNA's: evidence for transposition of sequences during synthesis and processing of subgenomic mRNA.
Journal of virology 1978;26(2):468-78.
1978: Lai M H; Verma I M
Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity.
Journal of virology 1978;25(2):652-63.
1977: Verma I M
The reverse transcriptase.
Biochimica et biophysica acta 1977;473(1):1-38.
1976: Verma I M; Varmus H E; Hunter E
Characterization of "early" temperature-sensitive mutants of avian sarcoma viruses: biological properties, thermolability of reverse transcriptase in vitro, and synthesis of viral DNA in infected cells.
Virology 1976;74(1):16-29.
1975: Tronick S R; Stephenson J R; Verma I M; Aaronson S A
Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions.
Journal of virology 1975;16(6):1476-82.
1975: Verma I M; Hunter E
Reverse transcriptase is coded for by the viral RNA.
Bibliotheca haematologica 1975;(43):457-9.
1975: Verma I M
Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.
Journal of virology 1975;15(4):843-54.
1975: Verma I M
Studies on reverse transcriptase of RNA tumor viruses. I. Localization of thermolabile DNA polymerase and RNase H activities on one polypeptide.
Journal of virology 1975;15(1):121-6.
1975: Panet A; Verma I M; Baltimore D
Role of the subunits of the avian RNA tumor virus reverse transcriptase.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 2():919-23.
1974: Gibson W; Verma I M
Studies on the reverse transcriptase of RNA tumor viruses. Structural relatedness of two subunits of avian RNA tumor viruses.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(12):4991-4.
1974: Forget B G; Marotta C A; Weissman S M; Verma I M; McCaffrey R P; Baltimore D
Nucleotide sequences of human globin messenger RNA.
Annals of the New York Academy of Sciences 1974;241(0):290-309.
1974: Baltimore D; Verma I M; Drost S; Mason W S
Temperature-sensitive DNA polymerase from Rous sarcoma virus mutants.
Cancer 1974;34(4 Suppl):suppl:1395-7.
1974: Verma I M; Firtel R A; Lodish H F; Baltimore D
Synthesis of DNA complementary to cellular slime mold messenger RNA by reverse transcriptase.
Biochemistry 1974;13(19):3917-22.
1974: Verma I M; Mason W S; Drost S D; Baltimore D
DNA polymerase activity from two temperature-sensitive mutants of Rous sarcoma virus is thermolabile.
Nature 1974;251(5470):27-31.
1974: Marotta C A; Forget B G; Weissman S M; Verma I M; McCaffrey R P; Baltimore D
Nucleotide sequences of human globin messenger RNA.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(6):2300-4.
1974: Verma I M; Meuth N L; Fan H; Baltimore D
Hamster leukemia virus: lack of endogenous DNA synthesis and unique structure of its DNA polymerase.
Journal of virology 1974;13(5):1075-82.
1974: Forget B G; Baltimore D; Benz E J; Housman D; Lebowitz P; Marotta C A; McCaffrey R P; Skoultchi A; Swerdlow P S; Verma I M; Weissman S M
Globin messenger RNA in the thalassemia syndromes.
Annals of the New York Academy of Sciences 1974;232(0):76-87.
1974: Verma I M; Baltimore D
Purification of the RNA-directed DNA polymerase from avian myeloblastosis virus and its assay with polynucleotide templates.
Methods in enzymology 1974;29(0):125-30.
1973: Berns A J; Bloemendal H; Kaufman S J; Verma I M
Synthesis of DNA complementary to 14S calf lens crystallin messenger RNA by reverse transcriptase.
Biochemical and biophysical research communications 1973;52(3):1013-9.
1973: Baltimore D; Verma I M; Smoler D F; Meuth N L
Avian myeloblastosis virus DNA polymerase: initiation of DNA synthesis and an associated ribonuclease.
Johns Hopkins medical journal. Supplement 1973;2():193-8.
1972: Verma I M; Temple G F; Fan H; Baltimore D
In vitro synthesis of DNA complementary to rabbit reticulocyte 10S RNA.
Nature: New biology 1972;235(58):163-7.
1971: Verma I M; Meuth N L; Bromfeld E; Manly K F; Baltimore D
Covalently linked RNA-DNA molecule as initial product of RNA tumour virus DNA polymerase.
Nature: New biology 1971;233(39):131-4.
1971: Edelman M; Verma I M; Herzog R; Galun E; Littauer U Z
Physico-chemical properties of mitochondrial ribosomal RNA from fungi.
European journal of biochemistry / FEBS 1971;19(3):372-8.
1971: Verma I M; Edelman M; Littauer U Z
A comparison of nucleotide sequences from mitochondrial and cytoplasmic ribosomal RNA of Aspergillus nidulans.
European journal of biochemistry / FEBS 1971;19(1):124-9.
1971: Edelman M; Verma I M; Saya D; Littauer U Z
Optical absorbance properties of mitochondrial ribosomal RNA.
Biochemical and biophysical research communications 1971;42(2):208-13.
1970: Verma I M; Edelman M; Herzberg M; Littauer U Z
Size determination of mitochondrial ribosomal RNA from Aspergillus nidulans by electron microscopy.
Journal of molecular biology 1970;52(1):137-40.
1970: Edelman M; Verma I M; Littauer U Z
Mitochondrial ribosomal RNA from Aspergillus nidulans: characterization of a novel molecular species.
Journal of molecular biology 1970;49(1):67-83.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Inder Verma

Research Profile (preview)

Living Beings

Chemicals & Drugs

Anatomy

Procedures

Physiology

Genes & Molecular Sequences

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Inder Verma (preview)

All Publications